Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study

This publication has 28 references indexed in Scilit:

• The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial Data
  Clinical Infectious Diseases, 2005
• Tigecycline MIC Testing by Broth Dilution Requires Use of Fresh Medium or Addition of the Biocatalytic Oxygen-Reducing Reagent Oxyrase To Standardize the Test Method
  Antimicrobial Agents and Chemotherapy, 2005
• In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)
  Diagnostic Microbiology and Infectious Disease, 2005
• Multiresistant acinetobacter in the UK: how big a threat?
  Journal of Hospital Infection, 2004
• Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors
  Clinical Infectious Diseases, 2004
• Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community and Private Health Care Centers
  Antimicrobial Agents and Chemotherapy, 2003
• Health and Economic Outcomes of Vancomycin-Resistant Enterococci
  Archives of internal medicine (1960), 2002
• In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in Spain
  Antimicrobial Agents and Chemotherapy, 2002
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
  Clinical Microbiology Reviews, 2001
• Comparative In Vitro Activities of Linezolid, Quinupristin-Dalfopristin, Moxifloxacin, and Trovafloxacin against Erythromycin-Susceptible and -Resistant Streptococci
  Antimicrobial Agents and Chemotherapy, 2000